CDXS codexis.com: Market Capitalization to Book Value Ratio

codexis.com (CDXS) - corporate logo

The asset price chart for Codexis, Inc. (CDXS) on GURU.Markets illustrates the dynamics of a company integrating ESG principles into the development of sustainable enzymes to reduce harmful emissions. The current indicator is 3.62. The business relies on a protein engineering platform, expanding its presence in the food industry and medicine to minimize niche risks. The scaling model is based on the sale of biocatalyst licenses, ensuring a stream of royalties without manufacturing costs.

codexis.com (CDXS): Capitalization to Book Value Ratio from 07/04/2022 to 10/27/2026
Finished products of codexis.com

This ratio determines the market price premium over net equity, reflecting the level of investor confidence in future cash flows relative to current assets. By analyzing this chart of the market-to-book multiple with a current value of 3.62, one can assess the extent to which the market capitalizes the intellectual potential of the CodeEvolver platform and the R&D expenditures of Codexis, Inc. in the field of biosynthesis.

Competitor analysis

Tempus Labs - Market Value to Book Value Ratio|qiagen.com (QGEN) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio Ionis (IONS)|Capitalization to Book Value Ratio RGEN|Market Value to Book Value Ratio Avidity RNA|Capitalization to Book Value Ratio CRISPR (CRSP)|Market Capitalization to Book Value Ratio WGS (GeneDx Holdings Corp.)|Market Capitalization to Book Value Ratio ultragenyx.com RARE|BEAM: Market Capitalization to Book Value Ratio|SRPT: Market Cap to Net Assets Ratio|Market Value to Book Value Ratio TWST|10x (TXG) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Intellia Therapeutics (NTLA)|Capitalization to Book Value Ratio stoketherapeutics.com|BioLife Solutions - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Wave Life Sciences Ltd WVE|MAZE - Market Cap to Net Assets Ratio|Capitalization to Book Value Ratio Sionna Corp SION|Market Capitalization to Book Value Ratio PRME (Prime Medicine, Inc.)|TSHA: Market Capitalization to Book Value|uniQure - Market Value to Book Value Ratio|Market Capitalization to Book Value MeiraGTx Holdings|RGNX - Market Cap to Net Assets Ratio|Market Value to Book Value Solid Corp|OCGN (Ocugen, Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value PACB (pacb.com)|BNTC - Market Value to Book Value Ratio|Capitalization to Book Value Ratio Design Therapeutics Inc DSGN|RCKT: Market Capitalization to Book Value Ratio|4D Molecular Corp (FDMT) - Market Cap to Net Assets Ratio|lexeotx.com - Market Cap to Net Assets Ratio|Korro Bio (KRRO) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio EDIT|Market Cap to Net Assets Ratio Silence Therapeutics PLC|Market Capitalization to Book Value Ratio ProQR Therapeutics N.V. PRQR|Capitalization to Book Value Ratio Sangamo BioSciences SGMO|NAUT - Market Cap to Net Assets Ratio|metagenomi.co - Capitalization to Book Value Ratio|Market Value to Book Value Ratio DTIL (Precision BioSciences)|GBIO - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio Boundless Bio, Inc|XCUR (Exicure) - Capitalization to Book Value Ratio|Market Value to Book Value Ratio Imunon Inc (IMNN)|Capitalization to Book Value Ratio RXi Pharmaceuticals|Market Capitalization to Book Value Ratio MBIO|Market Capitalization to Book Value Ratio transcodetherapeutics.com (RNAZ)|Bionano Genomics - Market Capitalization to Book Value Ratio|Applied DNA Corp - Market Cap to Net Assets Ratio|BLUE (bluebird bio, Inc.) - Market Value to Book Value Ratio|IPA - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Omega Therapeutics, Inc.|Singular Genomics Systems, Inc. (OMIC) - Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio RGLS (Regulus Therapeutics Inc)|Market-to-Book Ratio Syros Pharmaceuticals, Inc (SYRS)|Market Cap to Net Assets Ratio Telesis Bio, Inc. TBIO|Capitalization to Book Value Ratio traconpharma.com (TCON)|Market Capitalization to Book Value Ratio UBX